ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: New RFA, Program Announcements Coming Up Soon From BCDB for Radiation, Breast Cancer Studies

December 7, 1979

NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.

March 31, 2000

In Brief: Painter Is AMA President-Elect; FDA Approves Taxol; Protocol Enrolls 150-200 A Month

August 14, 1992

NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”

June 3, 1994

Cancer Genome Atlas Reveals Similarities Between Certain Breast and Ovarian Cancers

September 28, 2012

In Brief: Reynolds Retires “Joe Camel” advertising; Slaga Moves Lab To MC Cancer Center

July 18, 1997